Evolution of Costs of Inflammatory Bowel Disease over Two Years of Follow-Up

Author(s):
Valk, M.E. van der; Mangen, M.J.J.; Severs, M.; Have, M. van der; Dijkstra, G.; Bodegraven, A.A. van; Fidder, H.H.; Jong, D.J. de; Woude, C.J. van der; Romberg-Camps, M.J.L.; Clemens, C.H.M.; Jansen, J.M.; Meeberg, P.C.V. de; Mahmmod, N.; Meulen-de Jong, A.E. van der; Ponsioen, C.Y.; Bolwerk, C.; Vermeijden, J.R.; Siersema, P.D.; Leenders, M.; Oldenburg, B.; COIN Study Grp; Dutch Initiative Crohn Colitis
Published
2016
Publication type
Article / Letter to editor

Abstract

BD-related costs remained stable over two years. However, the proportion of anti-TNF-related healthcare costs increased, while hospitalization costs decreased. Factors associated with increased costs were penetrating disease course in CD and age <40 in UC.

Date issued
2016-04-21
Language
English
Publisher
PUBLIC LIBRARY SCIENCE
Is part of
PLoS ONE (2016), No. 4
hdl
1887/117206
doi
10.1371/journal.pone.0142481